Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Exercise in complicated pregnancies: no harm found in small study

NCT ID NCT06039319

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study involved 40 pregnant women whose babies were not growing well (fetal growth restriction). Researchers wanted to see if a single session of moderate exercise would change the baby's well-being. They measured the baby's health using ultrasound before and after the exercise. The goal was to gather information, not to treat or cure the condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

40 people

The number who actually took part.

Started

Nov 2022

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant individuals, between 28 weeks 0 days and 36 weeks 6 days gestational age with AGA or FGR.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inclusion Criteria - FGR population * Age 18-45 * Intrauterine pregnancy with diagnosis of fetal growth restriction (FGR) as defined by total estimated fetal weight \<10%ile for EGA or abdominal circumference \<10%ile for EGA * Diagnosis of FGR at any point in gestation (preference given for inclusion of those diagnosed with FGR after 32w0d) * Gestational age between 28w0d and 36w6d at time of intervention (based on sure last menstrual period (LMP) confirmed by first or second trimester ultrasound or unsure LMP with first trimester ultrasound) * Compliant with standard prenatal care Inclusion Criteria - Average for gestational age (AGA) population * Age 18-45 * Intrauterine pregnancy with normal estimated fetal growth (EFW \>10%ile and \<90%ile) * Gestational age between 28w0d and 36w6d at time of intervention with accurate dating (based on sure LMP confirmed by ultrasound prior to 22 weeks or unsure LMP with first trimester ultrasound) * Compliant with standard prenatal care Exclusion Criteria: * Exclusion Criteria - FGR population * Known contraindication to completion of 30 minutes of moderate intensity exercise * Fetal umbilical artery with elevated S/D ratio or absent or reversed diastolic flow * BMI \>40 * Severe maternal anemia (Hb less than 8.0) * Placenta previa * 2nd or 3rd trimester vaginal bleeding * Preterm premature rupture of membranes * Cervical insufficiency * Multi-fetal gestation * Oligohydramnios * Hypertensive disorder requiring antihypertensive medication * Blood pressure \>140/90 on the day of the study visit prior to exercise * Tobacco use * Opioid agonist therapy * Known fetal chromosomal anomaly, structural anomaly or infection * Inability or unwillingness of subject to give informed consent * Current psychiatric illness/social situation that would limit compliance with study requirements, as determined by the principle investigators Exclusion Criteria - AGA population * Known contraindication to completion of 30 minutes of moderate intensity exercise * BMI \>40 * Severe maternal anemia (Hb less than 8.0) * Placenta previa * 2nd or 3rd trimester vaginal bleeding * Preterm premature rupture of membranes * Cervical insufficiency * Multi-fetal gestation * Oligohydramnios * Hypertensive disorder requiring antihypertensive medication * Blood pressure \>140/90 on the day of the study visit prior to exercise * Tobacco use * Opioid agonist therapy * Known fetal chromosomal anomaly, structural anomaly or infection * Inability or unwillingness of subject to give informed consent * Current psychiatric illness/social situation that would limit compliance with study requirements, as determined by the principle investigators

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fetal growth complications are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Tennessee Graduate School of Medicine

    Knoxville, Tennessee, 37920, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.